Skip to main content

Table 2 Demographic and clinical data of subjects in the biomarker discovery cohort

From: Comparison of different statistical approaches for urinary peptide biomarker detection in the context of coronary artery disease

Parameter

DICADU control

DICADU case

VASCAB control

VASCAB case

AusDiab control

AusDiab case

CACTI control

CACTI case

N

20

19

46

47

72

72

3

3

Age

56 ± 7

54 ± 6

63 ± 8

63 ± 9

65 ± 11

65 ± 11

43 ± 4

44 ± 3

Female (%)

52.6

40.0

23.6

23.4

38.9

37.5

33.3

33.3

Gensini plaque score

0 ± 0

42 ± 28

0 ± 0

80 ± 31

n.a.

n.a.

n.a.

n.a.

Diabetes (%)

5.0

21.1

0

23.4

8.3

27.8

100

100

Current smoker (%)

20.0

21.1

4.3

6.4

4.2

22.2

33.3

33.3

Systolic blood pressure (mm Hg)

137 ± 18

133 ± 15

140 ± 17

139 ± 25

136 ± 19

147 ± 21

111 ± 10

122 ± 14

Diastolic blood pressure (mm Hg)

81 ± 10

78 ± 10

82 ± 11

79 ± 13

70 ± 11

76 ± 11

80 ± 10

87 ± 10

Total cholesterol (mmol/l)

5.2 ± 1.2

5.9 ± 0.3

5.6 ± 1.1

4.1 ± 0.9

6.2 ± 1.1

6.0 ± 1.2

4.8 ± 0.4

5.4 ± 0.7

HDL cholesterol (mmol/l)

1.2 ± 0.3

1.2 ± 0.3

1.5 ± 0.4

1.2 ± 0.3

1.5 ± 0.4

1.2 ± 0.4

1.3 ± 0.5

1.3 ± 0.6

Trigycerides (mmol/l)

2.0 ± 1.0

1.8 ± 0.8

1.6 ± 0.9

2.2 ± 1.0

n.a.

n.a.

1.1 ± 0.8

1.1 ± 0.5

  1. n.a. not available; Diabetes, type 2 except in CACTI where it is type I